During the past year they’ve filed more than a dozen class actions against Cipro manufacturer Bayer Ag and generic drug companies, claiming they conspired to keep lower cost versions of the drug off the market.

While the Cipro cases are among a string of suits alleging antitrust violations by the pharmaceutical industry, the anxiety over anthrax has brought them to the forefront.